NCOR1 and glioblastoma: In this report, we first proved elevated LAMP-2A and decreased N-CoR expression in GBM clinical samples, and demonstrated that LAMP-2A targeted N-CoR for CMA degradation and as a result promoted the proliferation of GBM by inhibiting UPR mediated apoptosis in GBM cell and nude mice xenograft models.